Simian parvovirus infection in cynomolgus monkey heart transplant recipients causes death related to severe anemia

Transplantation

Volumn 81, Issue 8, 2006, Pages 1165-1170

  Schröder, Carsten ^a,b   Pfeiffer, Steffen ^b,c   Wu, Guosheng ^a,b   Azimzadeh, Agnes M ^a,b   Aber, Amanda ^d   Pierson III, Richard N ^a,b   O'Sullivan, M Gerard ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c KLINIKUM NÜRNBERG   (Germany)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cynomolgus monkeys; Death related severe anemia; Heart transplantation; Human B19 parvovirus; Parvovirus infection

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCLONAL ANTIBODY IDEC 131; RECOMBINANT ERYTHROPOIETIN; THYMOCYTE ANTIBODY; VIRUS ANTIBODY;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; DONOR; DOT HYBRIDIZATION; ERYTHROID CELL; EXPLANT; GRAFT REJECTION; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LATENT VIRUS INFECTION; MALE; MONKEY; NONHUMAN; PARVOVIRUS; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SEROCONVERSION; SIMIAN PARVOVIRUS; SYMPTOMATOLOGY; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION;

ANEMIA; ANIMALS; ANTIBODIES, VIRAL; CAUSE OF DEATH; ERYTHROVIRUS; HEART TRANSPLANTATION; MACACA FASCICULARIS; MALE; MONKEY DISEASES; PARVOVIRIDAE INFECTIONS;

EID: 33646799766     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000203170.77195.e4     Document Type: Article

References (11)

1. O'Sullivan MG, Anderson DC, Fikes JD, et al. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia: a paradigm of human B19 parvovirus infection. J Clin Invest 1994; 93: 1571.
2. O'Sullivan MG, Anderson DC, Lund JE, et al. Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab Anim Sci 1996; 46: 291.
3. Brown KE, Liu Z, Gallinella G, et al. Simian parvovirus infection: a potential zoonosis. J Infect Dis 2004; 190: 1900-1907.
4. Brown KE, Green SW, O'Sullivan MG, Young NS. Cloning and sequencing of the simian parvovirus genome. Virology 1995; 210: 314.
5. Liu Z, Qiu J, Cheng F, et al. Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol 2004; 78: 12929-12939.
6. Yango A Jr., Morrissey P, Gohh R, Wahbeh A. Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 2002; 4: 163-166.
7. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994; 16: 1.
8. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257.
9. O'Sullivan MG, Anderson DK, Goodrich JA, et al. Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol 1997; 71: 4517.
10. Frustaci A, Chimenti C, Calabrese F, et al.Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863.
11. Bakhshi S, Sarnaik SA, Becker C, et al. Acute encephalopathy with parvovirus B19 infection in sickle cell disease. Arch Dis Child 2002; 87: 541-542.